SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

72,391.18 -247.52
( -0.34%)

Global Indices

Nasdaq

51,194.40 -347.88
(-0.67%)

Dow Jones

7,822.15 -17.78
(-0.23%)

Hang Seng

70,229.08 -454.90
(-0.64%)

Nikkei 225

10,456.95 -84.74
(-0.80%)

Forex

USD-INR

96.27 0.31
(0.32%)

EUR-INR

107.88 -0.09
(-0.09%)

GBP-INR

127.24 0.23
(0.18%)

JPY-INR

0.61 0.00
(0.27%)

YOU ARE HERE :
HOME
Markets
Equity
Profit and Loss

EQUITY - MARKET SCREENER

Bacil Pharma Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs

BSE Code

ISIN Demat

Book Value()

524516

INE711D01018

17.5541002

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

55.39

36.57

EPS(TTM)

Face Value()

Div & Yield %

0.46

Particulars(INCOME)	Mar 2026 ( Cr)	Mar 2025 ( Cr)	Mar 2024 ( Cr)	Mar 2023 ( Cr)	Mar 2022 ( Cr)	Mar 2021 ( Cr)
Sales Turnover	0.00	0.00	0.00	0.00	0.00	0.00
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	0.00	0.00	0.00	0.00	0.00	0.00
Other Income	1.24	0.66	0.13	0.11	0.06	0.07
Stock Adjustments	0.00	0.00	0.00	0.00	0.00	0.00
Total Income	1.24	0.66	0.13	0.11	0.06	0.07
EXPENDITURE :
Raw Materials	0.00	0.00	0.00	0.00	0.00	0.00
Power & Fuel Cost	0.00	0.00	0.00	0.00	0.00	0.00
Employee Cost	0.05	0.14	0.10	0.09	0.06	0.05
Other Manufacturing Expenses	0.00	0.00	0.00	0.00	0.00	0.00
Selling & Administrative Expenses	0.14	0.11	0.08	0.08	0.09	0.08
Miscellaneous Expenses	0.05	0.00	0.00	0.05	3.76	0.17
Less : Pre-operative Expenses Capitalised	0.00	0.00	0.00	0.00	0.00	0.00
Total Expenditure	0.25	0.25	0.19	0.21	3.91	0.30
Operating Profit	0.99	0.41	-0.06	-0.10	-3.86	-0.23
Interest	0.00	0.00	0.00	0.00	0.00	0.00
Gross Profit	0.99	0.41	-0.06	-0.10	-3.86	-0.23
Depreciation	0.00	0.00	0.00	0.00	0.00	0.00
Profit Before Tax	0.99	0.41	-0.06	-0.10	-3.86	-0.23
Tax	0.00	0.00	0.00	0.00	0.00	0.00
Fringe Benefit tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	-0.57	0.00	0.00	0.00	0.00	0.00
Reported Net Profit	1.56	0.40	-0.06	-0.10	-3.86	-0.24
Extraordinary Items	0.00	0.54	0.10	0.05	-3.76	-0.14
Adjusted Net Profit	1.56	-0.14	-0.16	-0.15	-0.10	-0.10
Adjustment below Net Profit	-2.17	16.37	0.17	-0.02	3.69	0.24
P & L Balance brought forward	11.46	-5.31	-5.43	-5.30	-5.14	-5.14
Statutory Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
P & L Balance carried down	10.84	11.46	-5.31	-5.43	-5.30	-5.14
Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Preference Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Equity Dividend %	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Per Share(Rs)	0.00	0.00	0.00	0.00	0.00	0.00
Earnings Per Share-Unit Curr	1.11	0.29	-0.09	-0.16	-5.91	-0.37
Earnings Per Share(Adj)-Unit Curr	1.11	0.29	-0.09	-0.16	-5.91	-0.37
Book Value-Unit Curr	17.76	18.20	1.86	1.68	1.88	2.13
Book Value(Adj)-Unit Curr	17.76	18.20	1.86	1.68	1.88	2.13

72,391.18 -247.52 ( -0.34%)

51,194.40 -347.88 (-0.67%)

7,822.15 -17.78 (-0.23%)

70,229.08 -454.90 (-0.64%)

10,456.95 -84.74 (-0.80%)

96.27 0.31 (0.32%)

107.88 -0.09 (-0.09%)

127.24 0.23 (0.18%)

0.61 0.00 (0.27%)